Merck Winning With Winrevair, Guarded On Gardasil In Q3

Third quarter sales for PAH drug Winrevair came in better than expected, while issues in China continued weighing on Gardasil.

Merck sign atop Merck Research Laboratories campus in South San Francisco
• Source: Shutterstock

More from Earnings

More from Scrip